Jin Hong

Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer

Renhong Huang, Han Wang, Jin Hong et al. · Frontiers in Immunology · 2023 · 104 citations · Full text

Medicine, Cancer Biology, Oncology +17

Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy

Renhong Huang, Zheng Wang, Jin Hong et al. · Cell Death and Disease · 2023 · 69 citations · Full text

Medicine, Immunology, Oncology +17

Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer

Jin Hong, Yan Mao, Xiaosong Chen et al. · Tumor Biology · 2015 · 43 citations

Medicine, Oncology, Hematologic Oncology +8

Early response and pathological complete remission in Breast Cancer with different molecular subtypes: a retrospective single center analysis

Jin Hong, Jiayi Wu, Ou Huang et al. · Journal of Cancer · 2020 · 31 citations · Full text

Medicine, Biostatistics, Oncology +16

<p>A high absolute lymphocyte count predicts a poor prognosis in HER-2- positive breast cancer patients treated with trastuzumab</p>

Jin Hong, Xiaosong Chen, Weiqi Gao et al. · Cancer Management and Research · 2019 · 21 citations · Full text

Medicine, Immunology, Oncology +16